Improving Photodynamic Therapy Anticancer Activity of a Mitochondria-Targeted Coumarin Photosensitizer Using a Polyurethane-Polyurea Hybrid Nanocarrier

Biomacromolecules. 2022 Jul 11;23(7):2900-2913. doi: 10.1021/acs.biomac.2c00361. Epub 2022 Jun 13.

Abstract

Integration of photosensitizers (PSs) within nanoscale delivery systems offers great potential for overcoming some of the "Achiles' heels" of photodynamic therapy (PDT). Herein, we have encapsulated a mitochondria-targeted coumarin PS into amphoteric polyurethane-polyurea hybrid nanocapsules (NCs) with the aim of developing novel nanoPDT agents. The synthesis of coumarin-loaded NCs involved the nanoemulsification of a suitable prepolymer in the presence of a PS without needing external surfactants, and the resulting small nanoparticles showed improved photostability compared with the free compound. Nanoencapsulation reduced dark cytotoxicity of the coumarin PS and significantly improved in vitro photoactivity with red light toward cancer cells, which resulted in higher phototherapeutic indexes compared to free PS. Importantly, this nanoformulation impaired tumoral growth of clinically relevant three-dimensional multicellular tumor spheroids. Mitochondrial photodamage along with reactive oxygen species (ROS) photogeneration was found to trigger autophagy and apoptotic cell death of cancer cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Coumarins / pharmacology
  • Humans
  • Mitochondria / metabolism
  • Nanoparticles*
  • Neoplasms* / pathology
  • Photochemotherapy* / methods
  • Photosensitizing Agents / pharmacology
  • Polymers
  • Polyurethanes / pharmacology
  • Reactive Oxygen Species / metabolism

Substances

  • Coumarins
  • Photosensitizing Agents
  • Polymers
  • Polyurethanes
  • Reactive Oxygen Species
  • polyurea